Cargando…
Correction to: A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
Autores principales: | Kim, Richard, Leal, Alexis D., Parikh, Aparna, Ryan, David P., Wang, Shining, Bahamon, Brittany, Gupta, Neeraj, Moss, Aaron, Pye, Joanna, Miao, Harry, Inguilizian, Haig, Cleary, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068635/ https://www.ncbi.nlm.nih.gov/pubmed/36967405 http://dx.doi.org/10.1007/s00280-023-04522-x |
Ejemplares similares
-
A phase I, first-in-human study of TAK-164, an antibody–drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
por: Kim, Richard, et al.
Publicado: (2023) -
Nucleotidyl Cyclase Activity of Particulate Guanylyl Cyclase A: Comparison with Particulate Guanylyl Cyclases E and F, Soluble Guanylyl Cyclase and Bacterial Adenylyl Cyclases Cyaa and Edema Factor
por: Beste, Kerstin Y., et al.
Publicado: (2013) -
Conjoined NO-sensitive guanylyl cyclases
por: Behrends, Sönke, et al.
Publicado: (2011) -
Guanylyl cyclase sees the light
por: Tesmer, John JG
Publicado: (2008) -
Nucleotidyl cyclase activity of recombinant soluble guanylyl cyclase
por: Rauch, Kerstin, et al.
Publicado: (2009)